S. Špánik

2.5k citations
79 papers · 1.4k indexed · h-index 20

S. Špánik

77 papers receiving 1.3k citations

Peers

S. Špánik
Comparison fields: 5 of 84
  • Clinical Biochemistry 151
  • Infectious Diseases 382
  • Oncology 556
  • Applied Microbiology and Biotechnology 32
  • Molecular Medicine 56
Replace Mary G. Boyle with:
Mary G. Boyle United States
Patricia García Chile
Ellis Tobin United States
Yongjung Park South Korea
Tsiporah B. Shore United States
Thibaud Koessler Switzerland
J F Silverman United States
Hamdi Akan Türkiye
Maria Bonora Italy
Manuel Santamarı́a Spain
S. Špánik relative to Mary G. Boyle United States Mary G. Boyle's profile →
Citations per field
00.5×3.3×
Mary G. Boyle · 1×
Citations per year

Countries citing papers authored by S. Špánik

Since Specialization
Citations

This map shows the geographic impact of S. Špánik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Špánik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Špánik more than expected).

Fields of papers citing papers by S. Špánik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Špánik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Špánik. The network helps show where S. Špánik may publish in the future.

Co-authorship network

The 25 scholars most cited alongside S. Špánik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Špánik Line = papers co-authored together S. Špánik links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201819
2 201876
3 201722
4 20166
5 2015180
6 201542
7 201424
8 200914
9 20087
10 19992
11 19997
12 199837
13 199716
14 199717
15 199733
16 19963
17 199618
18 19961
19 199523
20 19955

About S. Špánik

S. Špánik is a scholar working on Clinical Biochemistry, Oncology, Infectious Diseases, Reproductive Medicine and Cancer Research, having authored 79 papers that have together received 1.4k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (29 papers), Antifungal resistance and susceptibility (15 papers), Cancer Treatment and Pharmacology (15 papers), Bacterial Identification and Susceptibility Testing (14 papers), Testicular diseases and treatments (13 papers), Fungal Infections and Studies (10 papers), Sarcoma Diagnosis and Treatment (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Clinical Biochemistry (151 citations), Infectious Diseases (382 citations), Oncology (556 citations), Applied Microbiology and Biotechnology (32 citations) and Molecular Medicine (56 citations). S. Špánik has collaborated with scholars based in Slovakia, India and Malaysia. Frequent co-authors include V. Krčméry, J. Trupl, Jozef Mardiak, A. Kunová, Daniela Světlovská, Michal Mego, Michal Chovanec, Věra Miškovská, Katarína Rejleková and E. Kukučková. Their work appears in journals such as Journal of Clinical Oncology, Chemotherapy, Supportive Care in Cancer, Journal of Chemotherapy and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026